SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4j5x'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ERR_A_RALA600_1 (ESTROGEN RECEPTOR)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	5 / 12	ALA D 272 LEU D 276 TRP D 305 ARG D 316 ILE D 428	None	1.05A	1errA-4j5xD: 22.2	1errA-4j5xD: 29.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ERR_B_RALB600_1 (ESTROGEN RECEPTOR)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	5 / 12	ALA D 272 LEU D 276 TRP D 305 ARG D 316 ILE D 428	None	1.01A	1errB-4j5xD: 22.7	1errB-4j5xD: 29.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ERR_B_RALB600_1 (ESTROGEN RECEPTOR)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	5 / 12	ALA D 272 TRP D 305 LEU D 309 ARG D 316 ILE D 428	None	0.91A	1errB-4j5xD: 22.7	1errB-4j5xD: 29.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FBY_A_9CRA500_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	12 / 12	ILE D 268 CYH D 269 ALA D 271 ALA D 272 GLN D 275 PHE D 313 ARG D 316 LEU D 326 ALA D 327 VAL D 342 CYH D 432 HIS D 435	None	0.61A	1fbyA-4j5xD: 32.2	1fbyA-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FBY_B_9CRB1500_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	12 / 12	ILE D 268 CYH D 269 ALA D 271 ALA D 272 GLN D 275 PHE D 313 ARG D 316 LEU D 326 ALA D 327 VAL D 342 CYH D 432 HIS D 435	None	0.59A	1fbyB-4j5xD: 31.5	1fbyB-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FM6_A_9CRA501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	6 / 12	ALA D 271 ALA D 272 GLN D 275 TRP D 305 ARG D 316 LEU D 455	None	1.42A	1fm6A-4j5xD: 32.3	1fm6A-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FM6_A_9CRA501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	12 / 12	ILE D 268 ALA D 271 ALA D 272 GLN D 275 TRP D 305 PHE D 313 ARG D 316 LEU D 326 ALA D 327 VAL D 342 CYH D 432 LEU D 436	None	0.59A	1fm6A-4j5xD: 32.3	1fm6A-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FM6_U_9CRU502_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	11 / 12	ALA D 271 ALA D 272 PHE D 313 ARG D 316 LEU D 326 ALA D 327 VAL D 342 ILE D 345 CYH D 432 HIS D 435 LEU D 436	None	0.60A	1fm6U-4j5xD: 32.4	1fm6U-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FM6_U_9CRU502_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	6 / 12	PHE D 313 ARG D 316 ILE D 345 CYH D 432 HIS D 435 LEU D 433	None	1.34A	1fm6U-4j5xD: 32.4	1fm6U-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FM6_U_9CRU502_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	6 / 12	TRP D 305 VAL D 342 ILE D 345 CYH D 432 HIS D 435 LEU D 436	None	1.12A	1fm6U-4j5xD: 32.4	1fm6U-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FM9_A_9CRA201_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	7 / 12	ALA D 271 ALA D 272 TRP D 305 LEU D 309 ARG D 316 ALA D 327 LEU D 455	None	1.35A	1fm9A-4j5xD: 33.0	1fm9A-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FM9_A_9CRA201_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	12 / 12	ILE D 268 ALA D 271 ALA D 272 TRP D 305 LEU D 309 PHE D 313 ARG D 316 LEU D 326 ALA D 327 VAL D 342 CYH D 432 LEU D 436	None	0.55A	1fm9A-4j5xD: 33.0	1fm9A-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FM9_A_9CRA201_2 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	3 / 3	GLN D 275 ILE D 345 HIS D 435	None	0.42A	1fm9A-4j5xD: 33.0	1fm9A-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1G5Y_C_9CRC502_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	6 / 10	LEU D 309 SER D 312 PHE D 313 ARG D 316 LEU D 326 ALA D 327	None	0.67A	1g5yC-4j5xD: 25.4	1g5yC-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1K74_A_9CRA463_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	7 / 12	ALA D 271 ALA D 272 TRP D 305 LEU D 309 ARG D 316 ALA D 327 LEU D 455	None	1.39A	1k74A-4j5xD: 32.8	1k74A-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1K74_A_9CRA463_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	12 / 12	ILE D 268 ALA D 271 ALA D 272 TRP D 305 LEU D 309 PHE D 313 ARG D 316 LEU D 326 ALA D 327 VAL D 342 CYH D 432 LEU D 436	None	0.58A	1k74A-4j5xD: 32.8	1k74A-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1K74_A_9CRA463_2 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	3 / 3	GLN D 275 ILE D 345 HIS D 435	None	0.39A	1k74A-4j5xD: 32.8	1k74A-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1QKN_A_RALA600_1 (ESTROGEN RECEPTOR BETA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	6 / 12	ALA D 272 LEU D 309 ARG D 316 ILE D 345 ILE D 428 GLY D 429	None	1.01A	1qknA-4j5xD: 23.1	1qknA-4j5xD: 30.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XDK_A_9CRA500_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	11 / 12	ILE D 268 ALA D 271 GLN D 275 TRP D 305 ASN D 306 PHE D 313 ARG D 316 ALA D 327 VAL D 342 CYH D 432 LEU D 436	None	0.71A	1xdkA-4j5xD: 34.1	1xdkA-4j5xD: 99.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XDK_A_9CRA500_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	11 / 12	ILE D 268 ALA D 271 GLN D 275 TRP D 305 PHE D 313 ARG D 316 LEU D 326 ALA D 327 VAL D 342 CYH D 432 LEU D 436	None	0.60A	1xdkA-4j5xD: 34.1	1xdkA-4j5xD: 99.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XDK_E_9CRE1500_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	12 / 12	ILE D 268 ALA D 271 ALA D 272 GLN D 275 TRP D 305 PHE D 313 ARG D 316 LEU D 326 ALA D 327 VAL D 342 CYH D 432 LEU D 436	None	0.58A	1xdkE-4j5xD: 34.1	1xdkE-4j5xD: 99.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XDK_E_9CRE1500_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	6 / 12	ILE D 268 ALA D 271 GLN D 275 PHE D 313 VAL D 342 CYH D 432	None	1.44A	1xdkE-4j5xD: 34.1	1xdkE-4j5xD: 99.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XIU_A_9CRA201_1 (RXR-LIKE PROTEIN)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	12 / 12	ILE D 268 CYH D 269 ALA D 271 ALA D 272 GLN D 275 PHE D 313 ARG D 316 LEU D 326 ALA D 327 VAL D 342 CYH D 432 LEU D 436	None	0.55A	1xiuA-4j5xD: 30.5	1xiuA-4j5xD: 77.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XIU_B_9CRB202_1 (RXR-LIKE PROTEIN)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	12 / 12	ILE D 268 ALA D 271 ALA D 272 GLN D 275 LEU D 309 PHE D 313 ARG D 316 ALA D 327 VAL D 342 CYH D 432 HIS D 435 LEU D 436	None	0.48A	1xiuB-4j5xD: 34.3	1xiuB-4j5xD: 77.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XIU_B_9CRB202_1 (RXR-LIKE PROTEIN)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	6 / 12	ILE D 268 ALA D 271 GLN D 275 PHE D 313 VAL D 342 HIS D 435	None	1.47A	1xiuB-4j5xD: 34.3	1xiuB-4j5xD: 77.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XLS_A_9CRA801_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	12 / 12	ILE D 268 ALA D 271 ALA D 272 TRP D 305 LEU D 309 PHE D 313 ARG D 316 LEU D 326 ALA D 327 VAL D 342 CYH D 432 LEU D 436	None	0.48A	1xlsA-4j5xD: 33.6	1xlsA-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XLS_B_9CRB802_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	12 / 12	ILE D 268 ALA D 271 ALA D 272 TRP D 305 LEU D 309 PHE D 313 ARG D 316 LEU D 326 ALA D 327 VAL D 342 CYH D 432 LEU D 436	None	0.48A	1xlsB-4j5xD: 33.5	1xlsB-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XLS_C_9CRC803_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	12 / 12	ILE D 268 ALA D 271 ALA D 272 TRP D 305 LEU D 309 PHE D 313 ARG D 316 LEU D 326 ALA D 327 VAL D 342 CYH D 432 LEU D 436	None	0.48A	1xlsC-4j5xD: 33.5	1xlsC-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XLS_D_9CRD804_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	12 / 12	ILE D 268 ALA D 271 ALA D 272 TRP D 305 LEU D 309 PHE D 313 ARG D 316 LEU D 326 ALA D 327 VAL D 342 CYH D 432 LEU D 436	None	0.48A	1xlsD-4j5xD: 33.6	1xlsD-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ACL_A_REAA502_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	10 / 12	ALA D 271 ALA D 272 GLN D 275 ASN D 306 LEU D 309 PHE D 313 ARG D 316 ALA D 327 ILE D 345 CYH D 432	None	0.76A	2aclA-4j5xD: 28.4 2aclE-4j5xD: 28.3	2aclA-4j5xD: 100.00 2aclE-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ACL_A_REAA502_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	10 / 12	ALA D 271 ALA D 272 GLN D 275 LEU D 309 PHE D 313 ARG D 316 LEU D 326 ALA D 327 ILE D 345 CYH D 432	None	0.72A	2aclA-4j5xD: 28.4 2aclE-4j5xD: 28.3	2aclA-4j5xD: 100.00 2aclE-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ACL_C_REAC503_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	10 / 10	ILE D 268 ALA D 271 ALA D 272 GLN D 275 ASN D 306 PHE D 313 ARG D 316 ALA D 327 ILE D 345 CYH D 432	None	0.77A	2aclC-4j5xD: 28.5	2aclC-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ACL_E_REAE504_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	11 / 11	ILE D 268 ALA D 271 ALA D 272 GLN D 275 ASN D 306 LEU D 309 PHE D 313 ARG D 316 ALA D 327 ILE D 345 CYH D 432	None	0.80A	2aclE-4j5xD: 28.3	2aclE-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ACL_G_REAG501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	12 / 12	ILE D 268 ALA D 271 ALA D 272 GLN D 275 ASN D 306 LEU D 309 ILE D 310 PHE D 313 ARG D 316 LEU D 326 ALA D 327 CYH D 432	None	0.76A	2aclG-4j5xD: 27.7	2aclG-4j5xD: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JFA_A_RALA600_1 (ESTROGEN RECEPTOR)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	6 / 12	ALA D 272 LEU D 276 TRP D 305 LEU D 309 ARG D 316 ILE D 345	None	0.96A	2jfaA-4j5xD: 21.6	2jfaA-4j5xD: 25.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JFA_A_RALA600_1 (ESTROGEN RECEPTOR)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	6 / 12	ALA D 272 LEU D 276 TRP D 305 LEU D 309 ARG D 316 ILE D 428	None	1.08A	2jfaA-4j5xD: 21.6	2jfaA-4j5xD: 25.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JFA_A_RALA600_1 (ESTROGEN RECEPTOR)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	6 / 12	ALA D 272 TRP D 305 LEU D 309 ARG D 316 ILE D 345 LEU D 436	None	0.90A	2jfaA-4j5xD: 21.6	2jfaA-4j5xD: 25.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JFA_B_RALB600_1 (ESTROGEN RECEPTOR)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	6 / 12	ALA D 272 LEU D 276 TRP D 305 LEU D 309 ARG D 316 GLY D 429	None	0.94A	2jfaB-4j5xD: 21.2	2jfaB-4j5xD: 25.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JFA_B_RALB600_1 (ESTROGEN RECEPTOR)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	5 / 12	ALA D 272 TRP D 305 LEU D 309 ARG D 316 LEU D 436	None	0.80A	2jfaB-4j5xD: 21.2	2jfaB-4j5xD: 25.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2NV4_A_ACTA148_0 (UPF0066 PROTEIN AF_0241)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	3 / 3	VAL D 242 GLU D 239 GLU D 243	None	0.73A	2nv4A-4j5xD: undetectable	2nv4A-4j5xD: 21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QXS_A_RALA600_1 (ESTROGEN RECEPTOR)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	6 / 12	ALA D 272 LEU D 276 TRP D 305 LEU D 309 ARG D 316 ILE D 345	None	1.01A	2qxsA-4j5xD: 23.5	2qxsA-4j5xD: 29.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QXS_A_RALA600_1 (ESTROGEN RECEPTOR)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	6 / 12	ALA D 272 LEU D 276 TRP D 305 LEU D 309 ARG D 316 ILE D 428	None	1.08A	2qxsA-4j5xD: 23.5	2qxsA-4j5xD: 29.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QXS_A_RALA600_1 (ESTROGEN RECEPTOR)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	6 / 12	ALA D 272 TRP D 305 LEU D 309 ARG D 316 ILE D 345 LEU D 436	None	0.90A	2qxsA-4j5xD: 23.5	2qxsA-4j5xD: 29.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QXS_B_RALB600_1 (ESTROGEN RECEPTOR)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	5 / 12	ALA D 272 LEU D 276 TRP D 305 ARG D 316 ILE D 345	None	0.90A	2qxsB-4j5xD: 23.1	2qxsB-4j5xD: 29.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QXS_B_RALB600_1 (ESTROGEN RECEPTOR)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	5 / 12	ALA D 272 LEU D 276 TRP D 305 ARG D 316 ILE D 428	None	1.10A	2qxsB-4j5xD: 23.1	2qxsB-4j5xD: 29.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QXS_B_RALB600_1 (ESTROGEN RECEPTOR)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	6 / 12	ALA D 272 TRP D 305 LEU D 309 ARG D 316 ILE D 345 LEU D 436	None	0.93A	2qxsB-4j5xD: 23.1	2qxsB-4j5xD: 29.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QXS_B_RALB600_1 (ESTROGEN RECEPTOR)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	5 / 12	ALA D 272 TRP D 305 LEU D 309 ARG D 316 ILE D 428	None	0.92A	2qxsB-4j5xD: 23.1	2qxsB-4j5xD: 29.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3DZU_A_9CRA7223_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	12 / 12	ILE D 268 ALA D 271 GLN D 275 ASN D 306 ILE D 310 PHE D 313 ARG D 316 LEU D 326 VAL D 342 CYH D 432 HIS D 435 LEU D 436	None	0.68A	3dzuA-4j5xD: 31.7	3dzuA-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3DZY_A_9CRA463_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	8 / 12	GLN D 275 ASN D 306 SER D 312 ARG D 316 ALA D 327 VAL D 342 CYH D 432 LEU D 436	None	0.91A	3dzyA-4j5xD: 30.1	3dzyA-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3DZY_A_9CRA463_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	11 / 12	ILE D 268 ALA D 271 GLN D 275 ASN D 306 PHE D 313 ARG D 316 LEU D 326 ALA D 327 VAL D 342 CYH D 432 LEU D 436	None	0.71A	3dzyA-4j5xD: 30.1	3dzyA-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3E00_A_9CRA7223_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	11 / 12	ILE D 268 ALA D 271 ALA D 272 GLN D 275 TRP D 305 ASN D 306 PHE D 313 ALA D 327 VAL D 342 ILE D 345 CYH D 432	None	0.67A	3e00A-4j5xD: 32.2	3e00A-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3E00_A_9CRA7223_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	11 / 12	ILE D 268 ALA D 271 ALA D 272 GLN D 275 TRP D 305 PHE D 313 ARG D 316 ALA D 327 VAL D 342 ILE D 345 CYH D 432	None	0.58A	3e00A-4j5xD: 32.2	3e00A-4j5xD: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ERD_A_DESA600_1 (ESTROGEN RECEPTOR ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	5 / 12	ALA D 272 LEU D 309 ARG D 316 HIS D 435 LEU D 436	None	1.01A	3erdA-4j5xD: 24.3	3erdA-4j5xD: 28.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ERD_B_DESB800_1 (ESTROGEN RECEPTOR ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	5 / 10	ALA D 272 LEU D 309 ARG D 316 HIS D 435 LEU D 436	None	0.99A	3erdB-4j5xD: 25.0	3erdB-4j5xD: 28.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3FAL_A_REAA501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	10 / 10	ILE D 268 ALA D 271 ALA D 272 GLN D 275 PHE D 313 ARG D 316 ALA D 327 VAL D 342 ILE D 345 CYH D 432	None	0.57A	3falA-4j5xD: 27.8	3falA-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3FAL_A_REAA501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	7 / 10	ILE D 268 ALA D 271 GLN D 275 PHE D 313 VAL D 342 ILE D 345 CYH D 432	None	1.45A	3falA-4j5xD: 27.8	3falA-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3FAL_C_REAC501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	10 / 10	ILE D 268 ALA D 271 ALA D 272 GLN D 275 PHE D 313 ARG D 316 LEU D 326 ALA D 327 ILE D 345 CYH D 432	None	0.64A	3falC-4j5xD: 28.0	3falC-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3FC6_A_REAA501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	11 / 11	ILE D 268 ALA D 271 ALA D 272 GLN D 275 TRP D 305 PHE D 313 ARG D 316 LEU D 326 ALA D 327 ILE D 345 CYH D 432	None	0.63A	3fc6A-4j5xD: 28.7	3fc6A-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3FC6_C_REAC501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	12 / 12	VAL D 265 CYH D 269 ALA D 271 ALA D 272 GLN D 275 LEU D 309 PHE D 313 ARG D 316 LEU D 326 ALA D 327 VAL D 342 CYH D 432	None	0.64A	3fc6C-4j5xD: 29.0	3fc6C-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H0A_A_9RAA500_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	9 / 12	ALA D 271 ALA D 272 GLN D 275 LEU D 309 ARG D 316 LEU D 326 VAL D 342 ILE D 345 CYH D 432	None	0.87A	3h0aA-4j5xD: 30.9	3h0aA-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H0A_A_9RAA500_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	10 / 12	ALA D 271 ALA D 272 GLN D 275 TRP D 305 LEU D 309 ARG D 316 LEU D 326 VAL D 342 ILE D 345 LEU D 436	None	0.67A	3h0aA-4j5xD: 30.9	3h0aA-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H0A_A_9RAA500_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	9 / 12	ALA D 271 GLN D 275 LEU D 309 ARG D 316 LEU D 326 ALA D 327 VAL D 342 ILE D 345 CYH D 432	None	0.99A	3h0aA-4j5xD: 30.9	3h0aA-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H0A_A_9RAA500_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	7 / 12	ALA D 271 GLN D 275 TRP D 305 ARG D 316 LEU D 326 ALA D 327 ILE D 428	None	1.43A	3h0aA-4j5xD: 30.9	3h0aA-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H0A_A_9RAA500_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	10 / 12	ALA D 271 GLN D 275 TRP D 305 LEU D 309 ARG D 316 LEU D 326 ALA D 327 VAL D 342 ILE D 345 LEU D 436	None	0.80A	3h0aA-4j5xD: 30.9	3h0aA-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H0A_A_9RAA500_2 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	3 / 3	ILE D 268 PHE D 313 HIS D 435	None	0.61A	3h0aA-4j5xD: 30.9	3h0aA-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OAP_A_9CRA500_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	6 / 12	GLN D 275 PHE D 313 ARG D 316 ILE D 345 CYH D 432 LEU D 433	None	1.46A	3oapA-4j5xD: 34.6	3oapA-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OAP_A_9CRA500_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	12 / 12	ILE D 268 ALA D 271 ALA D 272 GLN D 275 PHE D 313 ARG D 316 LEU D 326 ALA D 327 VAL D 342 ILE D 345 CYH D 432 LEU D 436	None	0.56A	3oapA-4j5xD: 34.6	3oapA-4j5xD: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OLS_B_ESTB600_1 (ESTROGEN RECEPTOR BETA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	5 / 12	ALA D 272 LEU D 309 ARG D 316 ILE D 345 LEU D 436	None	1.03A	3olsB-4j5xD: 24.4	3olsB-4j5xD: 28.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	5 / 12	ALA D 272 LEU D 309 ARG D 316 ILE D 345 LEU D 436	None	0.97A	3q95A-4j5xD: 24.5	3q95A-4j5xD: 28.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	5 / 12	ALA D 272 LEU D 309 ARG D 316 ILE D 428 GLY D 429	None	0.96A	3q95A-4j5xD: 24.5	3q95A-4j5xD: 28.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	5 / 12	ALA D 272 LEU D 309 ARG D 316 ILE D 345 LEU D 436	None	0.95A	3q95B-4j5xD: 23.9	3q95B-4j5xD: 28.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	5 / 12	ALA D 272 LEU D 309 ARG D 316 ILE D 428 GLY D 429	None	0.98A	3q95B-4j5xD: 23.9	3q95B-4j5xD: 28.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3UVV_B_9CRB501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	12 / 12	ILE D 268 ALA D 271 ALA D 272 GLN D 275 LEU D 309 PHE D 313 ARG D 316 ALA D 327 VAL D 342 ILE D 345 CYH D 432 LEU D 436	None	0.48A	3uvvB-4j5xD: 35.4	3uvvB-4j5xD: 95.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4J24_D_ESTD600_1 (ESTROGEN RECEPTOR BETA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	5 / 12	ALA D 272 ARG D 316 ILE D 345 HIS D 435 LEU D 436	None	1.11A	4j24D-4j5xD: 24.1	4j24D-4j5xD: 28.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4K6I_A_9RAA500_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	11 / 12	ILE D 268 ALA D 271 ALA D 272 GLN D 275 LEU D 309 ILE D 310 PHE D 313 ARG D 316 LEU D 326 ALA D 327 VAL D 349	None	0.55A	4k6iA-4j5xD: 34.4	4k6iA-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4K6I_A_9RAA500_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	9 / 12	ILE D 268 ALA D 271 GLN D 275 ILE D 310 PHE D 313 ARG D 316 LEU D 326 ALA D 327 CYH D 432	None	0.84A	4k6iA-4j5xD: 34.4	4k6iA-4j5xD: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L1A_A_AB1A101_1 (MDR769 HIV-1 PROTEASE)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	5 / 11	GLY D 341 ALA D 340 ILE D 324 THR D 266 THR D 445	None	1.08A	4l1aA-4j5xD: undetectable	4l1aA-4j5xD: 16.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4NQA_A_9CRA501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	6 / 11	ILE D 268 ALA D 272 GLN D 275 PHE D 313 ARG D 316 ALA D 327	None	0.73A	4nqaA-4j5xD: 33.3	4nqaA-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4NQA_A_9CRA501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	10 / 11	ILE D 268 ALA D 272 GLN D 275 PHE D 313 LEU D 326 ALA D 327 VAL D 342 CYH D 432 HIS D 435 LEU D 436	None	0.74A	4nqaA-4j5xD: 33.3	4nqaA-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4NQA_H_9CRH501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	9 / 12	ILE D 268 ALA D 271 ALA D 272 GLN D 275 PHE D 313 ARG D 316 LEU D 326 ALA D 327 LEU D 436	None	0.58A	4nqaH-4j5xD: 33.2	4nqaH-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4NQA_H_9CRH501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	7 / 12	ILE D 268 ALA D 271 ALA D 272 ILE D 345 CYH D 432 HIS D 435 LEU D 436	None	0.65A	4nqaH-4j5xD: 33.2	4nqaH-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4NQA_H_9CRH501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	9 / 12	ILE D 268 ALA D 271 ALA D 272 PHE D 313 ARG D 316 ALA D 327 CYH D 432 HIS D 435 LEU D 436	None	0.66A	4nqaH-4j5xD: 33.2	4nqaH-4j5xD: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XI3_B_29SB601_1 (ESTROGEN RECEPTOR)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	6 / 12	ALA D 272 LEU D 276 TRP D 305 ARG D 316 ILE D 428 GLY D 429	None	1.12A	4xi3B-4j5xD: 23.0	4xi3B-4j5xD: 29.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XI3_B_29SB601_1 (ESTROGEN RECEPTOR)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	6 / 12	ALA D 272 TRP D 305 LEU D 309 ARG D 316 ILE D 428 GLY D 429	None	0.98A	4xi3B-4j5xD: 23.0	4xi3B-4j5xD: 29.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XI3_B_29SB601_1 (ESTROGEN RECEPTOR)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	5 / 12	ASP D 273 TRP D 305 LEU D 309 ARG D 316 LEU D 436	None	0.99A	4xi3B-4j5xD: 23.0	4xi3B-4j5xD: 29.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XI3_C_29SC601_1 (ESTROGEN RECEPTOR)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	5 / 12	ALA D 272 TRP D 305 LEU D 309 ARG D 316 GLY D 429	None	0.83A	4xi3C-4j5xD: 22.8	4xi3C-4j5xD: 29.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XI3_D_29SD601_1 (ESTROGEN RECEPTOR)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	5 / 12	ALA D 272 TRP D 305 LEU D 309 ARG D 316 LEU D 436	None	0.91A	4xi3D-4j5xD: 22.7	4xi3D-4j5xD: 29.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5JI0_A_9CRA501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	11 / 11	ILE D 268 GLN D 275 TRP D 305 LEU D 309 PHE D 313 ARG D 316 LEU D 326 ALA D 327 VAL D 342 CYH D 432 LEU D 436	None	0.52A	5ji0A-4j5xD: 32.4	5ji0A-4j5xD: 99.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UAN_A_9CRA503_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	12 / 12	ILE D 268 ALA D 271 ALA D 272 GLN D 275 TRP D 305 PHE D 313 ARG D 316 LEU D 326 ALA D 327 VAL D 342 CYH D 432 LEU D 436	None	0.74A	5uanA-4j5xD: 32.3	5uanA-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5Z12_B_9CRB501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	12 / 12	ILE D 268 ALA D 271 ALA D 272 TRP D 305 LEU D 309 PHE D 313 ARG D 316 LEU D 326 ALA D 327 VAL D 342 CYH D 432 LEU D 436	None	0.51A	5z12B-4j5xD: 34.2	5z12B-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5Z12_B_9CRB501_2 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	3 / 3	GLN D 275 ILE D 345 HIS D 435	None	0.50A	5z12B-4j5xD: 34.2	5z12B-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5Z12_C_9CRC501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	12 / 12	ILE D 268 ALA D 271 ALA D 272 GLN D 275 TRP D 305 PHE D 313 ARG D 316 LEU D 326 ALA D 327 VAL D 342 CYH D 432 LEU D 436	None	0.60A	5z12C-4j5xD: 32.0	5z12C-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6A5Y_D_9CRD501_0 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	7 / 12	ALA D 271 ALA D 272 GLN D 275 TRP D 305 ARG D 316 ALA D 327 LEU D 455	None	1.28A	6a5yD-4j5xD: 33.9	6a5yD-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6A5Y_D_9CRD501_0 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	12 / 12	ILE D 268 ALA D 271 ALA D 272 GLN D 275 TRP D 305 PHE D 313 ARG D 316 LEU D 326 ALA D 327 ILE D 345 CYH D 432 LEU D 436	None	0.57A	6a5yD-4j5xD: 33.9	6a5yD-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6A5Z_D_9CRD501_0 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	12 / 12	ILE D 268 ALA D 271 ALA D 272 GLN D 275 ILE D 310 PHE D 313 ARG D 316 LEU D 326 ALA D 327 ILE D 345 CYH D 432 LEU D 436	None	0.52A	6a5zD-4j5xD: 33.9	6a5zD-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6A5Z_L_9CRL501_0 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	12 / 12	ILE D 268 ALA D 271 ALA D 272 GLN D 275 PHE D 313 ARG D 316 LEU D 326 ALA D 327 ILE D 345 CYH D 432 HIS D 435 LEU D 436	None	0.56A	6a5zL-4j5xD: 33.3	6a5zL-4j5xD: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6A60_D_9CRD501_0 (RETINOIC ACID RECEPTOR RXR-ALPHA)	4j5x	RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1 (Homo sapiens)	12 / 12	ILE D 268 ALA D 271 ALA D 272 GLN D 275 LEU D 309 PHE D 313 ARG D 316 ALA D 327 ILE D 345 CYH D 432 HIS D 435 LEU D 436	None	0.48A	6a60D-4j5xD: 33.8	6a60D-4j5xD: 100.00

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1ERR_A_RALA600_1","ESTROGEN RECEPTOR","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",5,"ALA D 272;LEU D 276;TRP D 305;ARG D 316;ILE D 428","None","1.05A","1errA-4j5xD:22.2","1errA-4j5xD:29.51"],["1ERR_B_RALB600_1","ESTROGEN RECEPTOR","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",5,"ALA D 272;LEU D 276;TRP D 305;ARG D 316;ILE D 428","None","1.01A","1errB-4j5xD:22.7","1errB-4j5xD:29.51"],["1ERR_B_RALB600_1","ESTROGEN RECEPTOR","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",5,"ALA D 272;TRP D 305;LEU D 309;ARG D 316;ILE D 428","None","0.91A","1errB-4j5xD:22.7","1errB-4j5xD:29.51"],["1FBY_A_9CRA500_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",12,"ILE D 268;CYH D 269;ALA D 271;ALA D 272;GLN D 275;PHE D 313;ARG D 316;LEU D 326;ALA D 327;VAL D 342;CYH D 432;HIS D 435","None","0.61A","1fbyA-4j5xD:32.2","1fbyA-4j5xD:100.00"],["1FBY_B_9CRB1500_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",12,"ILE D 268;CYH D 269;ALA D 271;ALA D 272;GLN D 275;PHE D 313;ARG D 316;LEU D 326;ALA D 327;VAL D 342;CYH D 432;HIS D 435","None","0.59A","1fbyB-4j5xD:31.5","1fbyB-4j5xD:100.00"],["1FM6_A_9CRA501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",6,"ALA D 271;ALA D 272;GLN D 275;TRP D 305;ARG D 316;LEU D 455","None","1.42A","1fm6A-4j5xD:32.3","1fm6A-4j5xD:100.00"],["1FM6_A_9CRA501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",12,"ILE D 268;ALA D 271;ALA D 272;GLN D 275;TRP D 305;PHE D 313;ARG D 316;LEU D 326;ALA D 327;VAL D 342;CYH D 432;LEU D 436","None","0.59A","1fm6A-4j5xD:32.3","1fm6A-4j5xD:100.00"],["1FM6_U_9CRU502_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",11,"ALA D 271;ALA D 272;PHE D 313;ARG D 316;LEU D 326;ALA D 327;VAL D 342;ILE D 345;CYH D 432;HIS D 435;LEU D 436","None","0.60A","1fm6U-4j5xD:32.4","1fm6U-4j5xD:100.00"],["1FM6_U_9CRU502_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",6,"PHE D 313;ARG D 316;ILE D 345;CYH D 432;HIS D 435;LEU D 433","None","1.34A","1fm6U-4j5xD:32.4","1fm6U-4j5xD:100.00"],["1FM6_U_9CRU502_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",6,"TRP D 305;VAL D 342;ILE D 345;CYH D 432;HIS D 435;LEU D 436","None","1.12A","1fm6U-4j5xD:32.4","1fm6U-4j5xD:100.00"],["1FM9_A_9CRA201_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",7,"ALA D 271;ALA D 272;TRP D 305;LEU D 309;ARG D 316;ALA D 327;LEU D 455","None","1.35A","1fm9A-4j5xD:33.0","1fm9A-4j5xD:100.00"],["1FM9_A_9CRA201_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",12,"ILE D 268;ALA D 271;ALA D 272;TRP D 305;LEU D 309;PHE D 313;ARG D 316;LEU D 326;ALA D 327;VAL D 342;CYH D 432;LEU D 436","None","0.55A","1fm9A-4j5xD:33.0","1fm9A-4j5xD:100.00"],["1FM9_A_9CRA201_2","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",3,"GLN D 275;ILE D 345;HIS D 435","None","0.42A","1fm9A-4j5xD:33.0","1fm9A-4j5xD:100.00"],["1G5Y_C_9CRC502_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",6,"LEU D 309;SER D 312;PHE D 313;ARG D 316;LEU D 326;ALA D 327","None","0.67A","1g5yC-4j5xD:25.4","1g5yC-4j5xD:100.00"],["1K74_A_9CRA463_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",7,"ALA D 271;ALA D 272;TRP D 305;LEU D 309;ARG D 316;ALA D 327;LEU D 455","None","1.39A","1k74A-4j5xD:32.8","1k74A-4j5xD:100.00"],["1K74_A_9CRA463_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",12,"ILE D 268;ALA D 271;ALA D 272;TRP D 305;LEU D 309;PHE D 313;ARG D 316;LEU D 326;ALA D 327;VAL D 342;CYH D 432;LEU D 436","None","0.58A","1k74A-4j5xD:32.8","1k74A-4j5xD:100.00"],["1K74_A_9CRA463_2","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",3,"GLN D 275;ILE D 345;HIS D 435","None","0.39A","1k74A-4j5xD:32.8","1k74A-4j5xD:100.00"],["1QKN_A_RALA600_1","ESTROGEN RECEPTOR BETA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",6,"ALA D 272;LEU D 309;ARG D 316;ILE D 345;ILE D 428;GLY D 429","None","1.01A","1qknA-4j5xD:23.1","1qknA-4j5xD:30.66"],["1XDK_A_9CRA500_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",11,"ILE D 268;ALA D 271;GLN D 275;TRP D 305;ASN D 306;PHE D 313;ARG D 316;ALA D 327;VAL D 342;CYH D 432;LEU D 436","None","0.71A","1xdkA-4j5xD:34.1","1xdkA-4j5xD:99.15"],["1XDK_A_9CRA500_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",11,"ILE D 268;ALA D 271;GLN D 275;TRP D 305;PHE D 313;ARG D 316;LEU D 326;ALA D 327;VAL D 342;CYH D 432;LEU D 436","None","0.60A","1xdkA-4j5xD:34.1","1xdkA-4j5xD:99.15"],["1XDK_E_9CRE1500_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",12,"ILE D 268;ALA D 271;ALA D 272;GLN D 275;TRP D 305;PHE D 313;ARG D 316;LEU D 326;ALA D 327;VAL D 342;CYH D 432;LEU D 436","None","0.58A","1xdkE-4j5xD:34.1","1xdkE-4j5xD:99.15"],["1XDK_E_9CRE1500_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",6,"ILE D 268;ALA D 271;GLN D 275;PHE D 313;VAL D 342;CYH D 432","None","1.44A","1xdkE-4j5xD:34.1","1xdkE-4j5xD:99.15"],["1XIU_A_9CRA201_1","RXR-LIKE PROTEIN","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",12,"ILE D 268;CYH D 269;ALA D 271;ALA D 272;GLN D 275;PHE D 313;ARG D 316;LEU D 326;ALA D 327;VAL D 342;CYH D 432;LEU D 436","None","0.55A","1xiuA-4j5xD:30.5","1xiuA-4j5xD:77.82"],["1XIU_B_9CRB202_1","RXR-LIKE PROTEIN","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",12,"ILE D 268;ALA D 271;ALA D 272;GLN D 275;LEU D 309;PHE D 313;ARG D 316;ALA D 327;VAL D 342;CYH D 432;HIS D 435;LEU D 436","None","0.48A","1xiuB-4j5xD:34.3","1xiuB-4j5xD:77.82"],["1XIU_B_9CRB202_1","RXR-LIKE PROTEIN","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",6,"ILE D 268;ALA D 271;GLN D 275;PHE D 313;VAL D 342;HIS D 435","None","1.47A","1xiuB-4j5xD:34.3","1xiuB-4j5xD:77.82"],["1XLS_A_9CRA801_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",12,"ILE D 268;ALA D 271;ALA D 272;TRP D 305;LEU D 309;PHE D 313;ARG D 316;LEU D 326;ALA D 327;VAL D 342;CYH D 432;LEU D 436","None","0.48A","1xlsA-4j5xD:33.6","1xlsA-4j5xD:100.00"],["1XLS_B_9CRB802_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",12,"ILE D 268;ALA D 271;ALA D 272;TRP D 305;LEU D 309;PHE D 313;ARG D 316;LEU D 326;ALA D 327;VAL D 342;CYH D 432;LEU D 436","None","0.48A","1xlsB-4j5xD:33.5","1xlsB-4j5xD:100.00"],["1XLS_C_9CRC803_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",12,"ILE D 268;ALA D 271;ALA D 272;TRP D 305;LEU D 309;PHE D 313;ARG D 316;LEU D 326;ALA D 327;VAL D 342;CYH D 432;LEU D 436","None","0.48A","1xlsC-4j5xD:33.5","1xlsC-4j5xD:100.00"],["1XLS_D_9CRD804_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",12,"ILE D 268;ALA D 271;ALA D 272;TRP D 305;LEU D 309;PHE D 313;ARG D 316;LEU D 326;ALA D 327;VAL D 342;CYH D 432;LEU D 436","None","0.48A","1xlsD-4j5xD:33.6","1xlsD-4j5xD:100.00"],["2ACL_A_REAA502_1","RETINOIC ACID RECEPTOR RXR-ALPHA;RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",10,"ALA D 271;ALA D 272;GLN D 275;ASN D 306;LEU D 309;PHE D 313;ARG D 316;ALA D 327;ILE D 345;CYH D 432","None","0.76A","2aclA-4j5xD:28.4;2aclE-4j5xD:28.3","2aclA-4j5xD:100.00;2aclE-4j5xD:100.00"],["2ACL_A_REAA502_1","RETINOIC ACID RECEPTOR RXR-ALPHA;RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",10,"ALA D 271;ALA D 272;GLN D 275;LEU D 309;PHE D 313;ARG D 316;LEU D 326;ALA D 327;ILE D 345;CYH D 432","None","0.72A","2aclA-4j5xD:28.4;2aclE-4j5xD:28.3","2aclA-4j5xD:100.00;2aclE-4j5xD:100.00"],["2ACL_C_REAC503_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",10,"ILE D 268;ALA D 271;ALA D 272;GLN D 275;ASN D 306;PHE D 313;ARG D 316;ALA D 327;ILE D 345;CYH D 432","None","0.77A","2aclC-4j5xD:28.5","2aclC-4j5xD:100.00"],["2ACL_E_REAE504_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",11,"ILE D 268;ALA D 271;ALA D 272;GLN D 275;ASN D 306;LEU D 309;PHE D 313;ARG D 316;ALA D 327;ILE D 345;CYH D 432","None","0.80A","2aclE-4j5xD:28.3","2aclE-4j5xD:100.00"],["2ACL_G_REAG501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",12,"ILE D 268;ALA D 271;ALA D 272;GLN D 275;ASN D 306;LEU D 309;ILE D 310;PHE D 313;ARG D 316;LEU D 326;ALA D 327;CYH D 432","None","0.76A","2aclG-4j5xD:27.7","2aclG-4j5xD:100.00"],["2JFA_A_RALA600_1","ESTROGEN RECEPTOR","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",6,"ALA D 272;LEU D 276;TRP D 305;LEU D 309;ARG D 316;ILE D 345","None","0.96A","2jfaA-4j5xD:21.6","2jfaA-4j5xD:25.26"],["2JFA_A_RALA600_1","ESTROGEN RECEPTOR","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",6,"ALA D 272;LEU D 276;TRP D 305;LEU D 309;ARG D 316;ILE D 428","None","1.08A","2jfaA-4j5xD:21.6","2jfaA-4j5xD:25.26"],["2JFA_A_RALA600_1","ESTROGEN RECEPTOR","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",6,"ALA D 272;TRP D 305;LEU D 309;ARG D 316;ILE D 345;LEU D 436","None","0.90A","2jfaA-4j5xD:21.6","2jfaA-4j5xD:25.26"],["2JFA_B_RALB600_1","ESTROGEN RECEPTOR","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",6,"ALA D 272;LEU D 276;TRP D 305;LEU D 309;ARG D 316;GLY D 429","None","0.94A","2jfaB-4j5xD:21.2","2jfaB-4j5xD:25.26"],["2JFA_B_RALB600_1","ESTROGEN RECEPTOR","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",5,"ALA D 272;TRP D 305;LEU D 309;ARG D 316;LEU D 436","None","0.80A","2jfaB-4j5xD:21.2","2jfaB-4j5xD:25.26"],["2NV4_A_ACTA148_0","UPF0066 PROTEIN AF_0241","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",3,"VAL D 242;GLU D 239;GLU D 243","None","0.73A","2nv4A-4j5xD:undetectable","2nv4A-4j5xD:21.96"],["2QXS_A_RALA600_1","ESTROGEN RECEPTOR","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",6,"ALA D 272;LEU D 276;TRP D 305;LEU D 309;ARG D 316;ILE D 345","None","1.01A","2qxsA-4j5xD:23.5","2qxsA-4j5xD:29.72"],["2QXS_A_RALA600_1","ESTROGEN RECEPTOR","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",6,"ALA D 272;LEU D 276;TRP D 305;LEU D 309;ARG D 316;ILE D 428","None","1.08A","2qxsA-4j5xD:23.5","2qxsA-4j5xD:29.72"],["2QXS_A_RALA600_1","ESTROGEN RECEPTOR","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",6,"ALA D 272;TRP D 305;LEU D 309;ARG D 316;ILE D 345;LEU D 436","None","0.90A","2qxsA-4j5xD:23.5","2qxsA-4j5xD:29.72"],["2QXS_B_RALB600_1","ESTROGEN RECEPTOR","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",5,"ALA D 272;LEU D 276;TRP D 305;ARG D 316;ILE D 345","None","0.90A","2qxsB-4j5xD:23.1","2qxsB-4j5xD:29.72"],["2QXS_B_RALB600_1","ESTROGEN RECEPTOR","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",5,"ALA D 272;LEU D 276;TRP D 305;ARG D 316;ILE D 428","None","1.10A","2qxsB-4j5xD:23.1","2qxsB-4j5xD:29.72"],["2QXS_B_RALB600_1","ESTROGEN RECEPTOR","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",6,"ALA D 272;TRP D 305;LEU D 309;ARG D 316;ILE D 345;LEU D 436","None","0.93A","2qxsB-4j5xD:23.1","2qxsB-4j5xD:29.72"],["2QXS_B_RALB600_1","ESTROGEN RECEPTOR","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",5,"ALA D 272;TRP D 305;LEU D 309;ARG D 316;ILE D 428","None","0.92A","2qxsB-4j5xD:23.1","2qxsB-4j5xD:29.72"],["3DZU_A_9CRA7223_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",12,"ILE D 268;ALA D 271;GLN D 275;ASN D 306;ILE D 310;PHE D 313;ARG D 316;LEU D 326;VAL D 342;CYH D 432;HIS D 435;LEU D 436","None","0.68A","3dzuA-4j5xD:31.7","3dzuA-4j5xD:100.00"],["3DZY_A_9CRA463_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",8,"GLN D 275;ASN D 306;SER D 312;ARG D 316;ALA D 327;VAL D 342;CYH D 432;LEU D 436","None","0.91A","3dzyA-4j5xD:30.1","3dzyA-4j5xD:100.00"],["3DZY_A_9CRA463_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",11,"ILE D 268;ALA D 271;GLN D 275;ASN D 306;PHE D 313;ARG D 316;LEU D 326;ALA D 327;VAL D 342;CYH D 432;LEU D 436","None","0.71A","3dzyA-4j5xD:30.1","3dzyA-4j5xD:100.00"],["3E00_A_9CRA7223_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",11,"ILE D 268;ALA D 271;ALA D 272;GLN D 275;TRP D 305;ASN D 306;PHE D 313;ALA D 327;VAL D 342;ILE D 345;CYH D 432","None","0.67A","3e00A-4j5xD:32.2","3e00A-4j5xD:100.00"],["3E00_A_9CRA7223_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",11,"ILE D 268;ALA D 271;ALA D 272;GLN D 275;TRP D 305;PHE D 313;ARG D 316;ALA D 327;VAL D 342;ILE D 345;CYH D 432","None","0.58A","3e00A-4j5xD:32.2","3e00A-4j5xD:100.00"],["3ERD_A_DESA600_1","ESTROGEN RECEPTOR ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",5,"ALA D 272;LEU D 309;ARG D 316;HIS D 435;LEU D 436","None","1.01A","3erdA-4j5xD:24.3","3erdA-4j5xD:28.32"],["3ERD_B_DESB800_1","ESTROGEN RECEPTOR ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",5,"ALA D 272;LEU D 309;ARG D 316;HIS D 435;LEU D 436","None","0.99A","3erdB-4j5xD:25.0","3erdB-4j5xD:28.32"],["3FAL_A_REAA501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",10,"ILE D 268;ALA D 271;ALA D 272;GLN D 275;PHE D 313;ARG D 316;ALA D 327;VAL D 342;ILE D 345;CYH D 432","None","0.57A","3falA-4j5xD:27.8","3falA-4j5xD:100.00"],["3FAL_A_REAA501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",7,"ILE D 268;ALA D 271;GLN D 275;PHE D 313;VAL D 342;ILE D 345;CYH D 432","None","1.45A","3falA-4j5xD:27.8","3falA-4j5xD:100.00"],["3FAL_C_REAC501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",10,"ILE D 268;ALA D 271;ALA D 272;GLN D 275;PHE D 313;ARG D 316;LEU D 326;ALA D 327;ILE D 345;CYH D 432","None","0.64A","3falC-4j5xD:28.0","3falC-4j5xD:100.00"],["3FC6_A_REAA501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",11,"ILE D 268;ALA D 271;ALA D 272;GLN D 275;TRP D 305;PHE D 313;ARG D 316;LEU D 326;ALA D 327;ILE D 345;CYH D 432","None","0.63A","3fc6A-4j5xD:28.7","3fc6A-4j5xD:100.00"],["3FC6_C_REAC501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",12,"VAL D 265;CYH D 269;ALA D 271;ALA D 272;GLN D 275;LEU D 309;PHE D 313;ARG D 316;LEU D 326;ALA D 327;VAL D 342;CYH D 432","None","0.64A","3fc6C-4j5xD:29.0","3fc6C-4j5xD:100.00"],["3H0A_A_9RAA500_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",9,"ALA D 271;ALA D 272;GLN D 275;LEU D 309;ARG D 316;LEU D 326;VAL D 342;ILE D 345;CYH D 432","None","0.87A","3h0aA-4j5xD:30.9","3h0aA-4j5xD:100.00"],["3H0A_A_9RAA500_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",10,"ALA D 271;ALA D 272;GLN D 275;TRP D 305;LEU D 309;ARG D 316;LEU D 326;VAL D 342;ILE D 345;LEU D 436","None","0.67A","3h0aA-4j5xD:30.9","3h0aA-4j5xD:100.00"],["3H0A_A_9RAA500_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",9,"ALA D 271;GLN D 275;LEU D 309;ARG D 316;LEU D 326;ALA D 327;VAL D 342;ILE D 345;CYH D 432","None","0.99A","3h0aA-4j5xD:30.9","3h0aA-4j5xD:100.00"],["3H0A_A_9RAA500_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",7,"ALA D 271;GLN D 275;TRP D 305;ARG D 316;LEU D 326;ALA D 327;ILE D 428","None","1.43A","3h0aA-4j5xD:30.9","3h0aA-4j5xD:100.00"],["3H0A_A_9RAA500_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",10,"ALA D 271;GLN D 275;TRP D 305;LEU D 309;ARG D 316;LEU D 326;ALA D 327;VAL D 342;ILE D 345;LEU D 436","None","0.80A","3h0aA-4j5xD:30.9","3h0aA-4j5xD:100.00"],["3H0A_A_9RAA500_2","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",3,"ILE D 268;PHE D 313;HIS D 435","None","0.61A","3h0aA-4j5xD:30.9","3h0aA-4j5xD:100.00"],["3OAP_A_9CRA500_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",6,"GLN D 275;PHE D 313;ARG D 316;ILE D 345;CYH D 432;LEU D 433","None","1.46A","3oapA-4j5xD:34.6","3oapA-4j5xD:100.00"],["3OAP_A_9CRA500_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",12,"ILE D 268;ALA D 271;ALA D 272;GLN D 275;PHE D 313;ARG D 316;LEU D 326;ALA D 327;VAL D 342;ILE D 345;CYH D 432;LEU D 436","None","0.56A","3oapA-4j5xD:34.6","3oapA-4j5xD:100.00"],["3OLS_B_ESTB600_1","ESTROGEN RECEPTOR BETA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",5,"ALA D 272;LEU D 309;ARG D 316;ILE D 345;LEU D 436","None","1.03A","3olsB-4j5xD:24.4","3olsB-4j5xD:28.62"],["3Q95_A_ESLA700_1","ESTROGEN RECEPTOR","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",5,"ALA D 272;LEU D 309;ARG D 316;ILE D 345;LEU D 436","None","0.97A","3q95A-4j5xD:24.5","3q95A-4j5xD:28.91"],["3Q95_A_ESLA700_1","ESTROGEN RECEPTOR","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",5,"ALA D 272;LEU D 309;ARG D 316;ILE D 428;GLY D 429","None","0.96A","3q95A-4j5xD:24.5","3q95A-4j5xD:28.91"],["3Q95_B_ESLB700_1","ESTROGEN RECEPTOR","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",5,"ALA D 272;LEU D 309;ARG D 316;ILE D 345;LEU D 436","None","0.95A","3q95B-4j5xD:23.9","3q95B-4j5xD:28.91"],["3Q95_B_ESLB700_1","ESTROGEN RECEPTOR","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",5,"ALA D 272;LEU D 309;ARG D 316;ILE D 428;GLY D 429","None","0.98A","3q95B-4j5xD:23.9","3q95B-4j5xD:28.91"],["3UVV_B_9CRB501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",12,"ILE D 268;ALA D 271;ALA D 272;GLN D 275;LEU D 309;PHE D 313;ARG D 316;ALA D 327;VAL D 342;ILE D 345;CYH D 432;LEU D 436","None","0.48A","3uvvB-4j5xD:35.4","3uvvB-4j5xD:95.56"],["4J24_D_ESTD600_1","ESTROGEN RECEPTOR BETA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",5,"ALA D 272;ARG D 316;ILE D 345;HIS D 435;LEU D 436","None","1.11A","4j24D-4j5xD:24.1","4j24D-4j5xD:28.62"],["4K6I_A_9RAA500_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",11,"ILE D 268;ALA D 271;ALA D 272;GLN D 275;LEU D 309;ILE D 310;PHE D 313;ARG D 316;LEU D 326;ALA D 327;VAL D 349","None","0.55A","4k6iA-4j5xD:34.4","4k6iA-4j5xD:100.00"],["4K6I_A_9RAA500_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",9,"ILE D 268;ALA D 271;GLN D 275;ILE D 310;PHE D 313;ARG D 316;LEU D 326;ALA D 327;CYH D 432","None","0.84A","4k6iA-4j5xD:34.4","4k6iA-4j5xD:100.00"],["4L1A_A_AB1A101_1","MDR769 HIV-1 PROTEASE","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",5,"GLY D 341;ALA D 340;ILE D 324;THR D 266;THR D 445","None","1.08A","4l1aA-4j5xD:undetectable","4l1aA-4j5xD:16.28"],["4NQA_A_9CRA501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",6,"ILE D 268;ALA D 272;GLN D 275;PHE D 313;ARG D 316;ALA D 327","None","0.73A","4nqaA-4j5xD:33.3","4nqaA-4j5xD:100.00"],["4NQA_A_9CRA501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",10,"ILE D 268;ALA D 272;GLN D 275;PHE D 313;LEU D 326;ALA D 327;VAL D 342;CYH D 432;HIS D 435;LEU D 436","None","0.74A","4nqaA-4j5xD:33.3","4nqaA-4j5xD:100.00"],["4NQA_H_9CRH501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",9,"ILE D 268;ALA D 271;ALA D 272;GLN D 275;PHE D 313;ARG D 316;LEU D 326;ALA D 327;LEU D 436","None","0.58A","4nqaH-4j5xD:33.2","4nqaH-4j5xD:100.00"],["4NQA_H_9CRH501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",7,"ILE D 268;ALA D 271;ALA D 272;ILE D 345;CYH D 432;HIS D 435;LEU D 436","None","0.65A","4nqaH-4j5xD:33.2","4nqaH-4j5xD:100.00"],["4NQA_H_9CRH501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",9,"ILE D 268;ALA D 271;ALA D 272;PHE D 313;ARG D 316;ALA D 327;CYH D 432;HIS D 435;LEU D 436","None","0.66A","4nqaH-4j5xD:33.2","4nqaH-4j5xD:100.00"],["4XI3_B_29SB601_1","ESTROGEN RECEPTOR","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",6,"ALA D 272;LEU D 276;TRP D 305;ARG D 316;ILE D 428;GLY D 429","None","1.12A","4xi3B-4j5xD:23.0","4xi3B-4j5xD:29.14"],["4XI3_B_29SB601_1","ESTROGEN RECEPTOR","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",6,"ALA D 272;TRP D 305;LEU D 309;ARG D 316;ILE D 428;GLY D 429","None","0.98A","4xi3B-4j5xD:23.0","4xi3B-4j5xD:29.14"],["4XI3_B_29SB601_1","ESTROGEN RECEPTOR","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",5,"ASP D 273;TRP D 305;LEU D 309;ARG D 316;LEU D 436","None","0.99A","4xi3B-4j5xD:23.0","4xi3B-4j5xD:29.14"],["4XI3_C_29SC601_1","ESTROGEN RECEPTOR","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",5,"ALA D 272;TRP D 305;LEU D 309;ARG D 316;GLY D 429","None","0.83A","4xi3C-4j5xD:22.8","4xi3C-4j5xD:29.14"],["4XI3_D_29SD601_1","ESTROGEN RECEPTOR","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",5,"ALA D 272;TRP D 305;LEU D 309;ARG D 316;LEU D 436","None","0.91A","4xi3D-4j5xD:22.7","4xi3D-4j5xD:29.14"],["5JI0_A_9CRA501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",11,"ILE D 268;GLN D 275;TRP D 305;LEU D 309;PHE D 313;ARG D 316;LEU D 326;ALA D 327;VAL D 342;CYH D 432;LEU D 436","None","0.52A","5ji0A-4j5xD:32.4","5ji0A-4j5xD:99.58"],["5UAN_A_9CRA503_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",12,"ILE D 268;ALA D 271;ALA D 272;GLN D 275;TRP D 305;PHE D 313;ARG D 316;LEU D 326;ALA D 327;VAL D 342;CYH D 432;LEU D 436","None","0.74A","5uanA-4j5xD:32.3","5uanA-4j5xD:100.00"],["5Z12_B_9CRB501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",12,"ILE D 268;ALA D 271;ALA D 272;TRP D 305;LEU D 309;PHE D 313;ARG D 316;LEU D 326;ALA D 327;VAL D 342;CYH D 432;LEU D 436","None","0.51A","5z12B-4j5xD:34.2","5z12B-4j5xD:100.00"],["5Z12_B_9CRB501_2","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",3,"GLN D 275;ILE D 345;HIS D 435","None","0.50A","5z12B-4j5xD:34.2","5z12B-4j5xD:100.00"],["5Z12_C_9CRC501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",12,"ILE D 268;ALA D 271;ALA D 272;GLN D 275;TRP D 305;PHE D 313;ARG D 316;LEU D 326;ALA D 327;VAL D 342;CYH D 432;LEU D 436","None","0.60A","5z12C-4j5xD:32.0","5z12C-4j5xD:100.00"],["6A5Y_D_9CRD501_0","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",7,"ALA D 271;ALA D 272;GLN D 275;TRP D 305;ARG D 316;ALA D 327;LEU D 455","None","1.28A","6a5yD-4j5xD:33.9","6a5yD-4j5xD:100.00"],["6A5Y_D_9CRD501_0","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",12,"ILE D 268;ALA D 271;ALA D 272;GLN D 275;TRP D 305;PHE D 313;ARG D 316;LEU D 326;ALA D 327;ILE D 345;CYH D 432;LEU D 436","None","0.57A","6a5yD-4j5xD:33.9","6a5yD-4j5xD:100.00"],["6A5Z_D_9CRD501_0","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",12,"ILE D 268;ALA D 271;ALA D 272;GLN D 275;ILE D 310;PHE D 313;ARG D 316;LEU D 326;ALA D 327;ILE D 345;CYH D 432;LEU D 436","None","0.52A","6a5zD-4j5xD:33.9","6a5zD-4j5xD:100.00"],["6A5Z_L_9CRL501_0","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",12,"ILE D 268;ALA D 271;ALA D 272;GLN D 275;PHE D 313;ARG D 316;LEU D 326;ALA D 327;ILE D 345;CYH D 432;HIS D 435;LEU D 436","None","0.56A","6a5zL-4j5xD:33.3","6a5zL-4j5xD:100.00"],["6A60_D_9CRD501_0","RETINOIC ACID RECEPTOR RXR-ALPHA","4j5x","RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COACTIVATOR 1","Homo sapiens",12,"ILE D 268;ALA D 271;ALA D 272;GLN D 275;LEU D 309;PHE D 313;ARG D 316;ALA D 327;ILE D 345;CYH D 432;HIS D 435;LEU D 436","None","0.48A","6a60D-4j5xD:33.8","6a60D-4j5xD:100.00"]]